FINANCIAL COST AND MORTALITY ASSOCIATED WITH CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS IN A CONTEMPORARY COHORT OF MEDICARE BENEFICIARIES

Cardiovascular implantable electronic device infections: associated risk factors and prevention.

Infections of cardiovascular implantable electric devices (CIED) are a burden on patients and healthcare systems and should be prevented. The most frequent pathogens are coagulase-negative staphylococci and Staphylococcus aureus. The most important risk factors for CIED infections are diabetes mellitus, renal and heart failure, corticosteroid use, oral anticoagulation, fever within 24 hours bef...

Microbiology and pathogenesis of cardiovascular implantable electronic device infections.

Advancements in our understanding of cardiac conduction abnormalities and pathophysiology of congestive heart failure coupled with innovations in device manufacturing and programming have helped to create a demand for a plethora of newer cardiovascular devices over the past 3 decades. Appropriate use of cardiovascular implantable electronic devices (CIEDs) in carefully selected patients is asso...

Advances in Arrhythmia and Electrophysiology Microbiology and Pathogenesis of Cardiovascular Implantable Electronic Device Infections

Advancements in our understanding of cardiac conduction abnormalities and pathophysiology of congestive heart failure coupled with innovations in device manufacturing and programming have helped to create a demand for a plethora of newer cardiovascular devices over the past 3 decades. Appropriate use of cardiovascular implantable electronic devices (CIEDs) in carefully selected patients is asso...

Health Care Cost and Utilization Associated With Alpha-1 Antitrypsin Deficiency Among A Cohort of Medicare Beneficiaries With Copd.

test, Wilcoxon test, Chi-square test) were: number of patients exposed to allogeneic red cells, amount of blood transfusions, and the number of length of stay in hospital. An economic model was quantified the cost saving of EVICEL® in ICH. Results: preliminary results showed that application of EVICEL reduce number of transfused RBC, postoperative haemoglobin loss, and days of hospital stay. In...

Cardiovascular implantable electronic device infection: a complication of medical progress.